tiprankstipranks
Meilleure Health International Industry Group Limited (HK:2327)
:2327
Hong Kong Market
2327
Meilleure Health International Industry Group Limited
RESEARCH TOOLSreports

Meilleure Health International Industry Group Limited (2327) Income Statement

Compare
0 Followers

Meilleure Health International Industry Group Limited Income Statement

Last quarter (Q2 2024), Meilleure Health International Industry Group Limited's total revenue was HK$30.03M, a decrease of -53.52% from the same quarter last year. In Q2, Meilleure Health International Industry Group Limited's net income was HK$8.46M. See Meilleure Health International Industry Group Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
HK$ 129.30MHK$ 119.89MHK$ 253.03MHK$ 265.13MHK$ 234.78M
Gross Profit
HK$ 78.09MHK$ 66.76MHK$ 100.93MHK$ 111.25MHK$ 71.83M
Operating Expenses
HK$ 78.09MHK$ 33.08MHK$ 42.19MHK$ 48.04MHK$ 38.98M
Depreciation and Amortization
HK$ 2.64MHK$ 3.85MHK$ 3.58MHK$ 7.91MHK$ 6.19M
EBITDA
HK$ 71.38MHK$ 58.50MHK$ 70.55MHK$ 59.97MHK$ 12.38M
Operating Income
HK$ 35.38MHK$ 54.65MHK$ 66.98MHK$ 52.06MHK$ 6.19M
Other Income/Expenses
HK$ 17.60MHK$ -8.30MHK$ 28.36MHK$ 42.92MHK$ -31.88M
Pretax Income
HK$ 52.98MHK$ 25.39MHK$ 85.70MHK$ 103.59MHK$ -5.34M
Net Income
HK$ 40.83MHK$ 17.82MHK$ 60.32MHK$ 83.44MHK$ -23.01M
Per Share Metrics
HK$ ―HK$ ―HK$ ―HK$ ―HK$ ―
Basic EPS
HK$ 0.01HK$ 0.00HK$ 0.01HK$ 0.02HK$ -0.01
Diluted EPS
HK$ 0.01HK$ 0.00HK$ 0.01HK$ 0.02HK$ -0.01
Weighted Average Shares Outstanding
4.09B 4.11B 4.26B 4.27B 4.17B
Weighted Average Shares Outstanding (Diluted)
4.09B 4.11B 4.27B 4.27B 4.17B
Currency in HKD

Meilleure Health International Industry Group Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis